Barber LD - Search Results

1

Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.

Whitelegg AM, Oosten LE, Jordan S, Kester M, van Halteren AG, Madrigal JA, Goulmy E, Barber LD. Whitelegg AM, et al. Among authors: barber ld. J Immunol. 2005 Aug 1;175(3):1706-14. doi: 10.4049/jimmunol.175.3.1706. J Immunol. 2005. PMID: 16034111

2

The structural basis of T-cell allorecognition.

Whitelegg A, Barber LD. Whitelegg A, et al. Among authors: barber ld. Tissue Antigens. 2004 Feb;63(2):101-8. doi: 10.1111/j.1399-0039.2004.00188.x. Tissue Antigens. 2004. PMID: 14705981 Review.

3

Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients.

Barber LD, Whitelegg A, Madrigal JA, Banner NR, Rose ML. Barber LD, et al. Transplantation. 2004 May 27;77(10):1604-9. doi: 10.1097/01.tp.0000129068.03900.25. Transplantation. 2004. PMID: 15239629

4

HLA class I mono-specific APCs and target cells: a method to standardise in vitro CD8+ T cell expansion and functional assays.

Barber LD, Jordan S, Whitelegg AM, Madrigal JA, Savage P. Barber LD, et al. J Immunol Methods. 2006 Jul 31;314(1-2):147-52. doi: 10.1016/j.jim.2006.06.008. Epub 2006 Jul 5. J Immunol Methods. 2006. PMID: 16872625

5

Exploiting beneficial alloreactive T cells.

Barber LD, Madrigal JA. Barber LD, et al. Vox Sang. 2006 Jul;91(1):20-7. doi: 10.1111/j.1423-0410.2006.00775.x. Vox Sang. 2006. PMID: 16756597 Review.

6

A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease.

Guppy AE, Rawlings E, Madrigal JA, Amlot PL, Barber LD. Guppy AE, et al. Among authors: barber ld. Transplantation. 2007 Dec 15;84(11):1534-9. doi: 10.1097/01.tp.0000290232.65830.e7. Transplantation. 2007. PMID: 18091531

7

Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.

Matthews K, Lim Z, Afzali B, Pearce L, Abdallah A, Kordasti S, Pagliuca A, Lombardi G, Madrigal JA, Mufti GJ, Barber LD. Matthews K, et al. Among authors: barber ld. Haematologica. 2009 Jul;94(7):956-66. doi: 10.3324/haematol.2008.003103. Epub 2009 Jun 2. Haematologica. 2009. PMID: 19491336 Free PMC article. Clinical Trial.

8

Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.

Barber LD, Lechler RI. Barber LD, et al. J Immunol. 1991 Oct 1;147(7):2346-53. J Immunol. 1991. PMID: 1717556

9

Interactions of HLA-B*4801 with peptide and CD8.

Martinez-Naves E, Barber LD, Madrigal JA, Vullo CM, Clayberger C, Lyu SC, Williams RC, Gorodezky C, Markow T, Petzl-Erler ML, Parham P. Martinez-Naves E, et al. Among authors: barber ld. Tissue Antigens. 1997 Sep;50(3):258-64. doi: 10.1111/j.1399-0039.1997.tb02869.x. Tissue Antigens. 1997. PMID: 9331948

10

Structural analysis of anti-DR1 allorecognition by using DR1/H-2Ek hybrid molecules. Influence of the beta 2-domain correlates with CD4 dependence.

Lombardi G, Barber L, Aichinger G, Heaton T, Sidhu S, Batchelor JR, Lechler RI. Lombardi G, et al. J Immunol. 1991 Sep 15;147(6):2034-40. J Immunol. 1991. PMID: 1716292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters